U.S. CDC updates recommendation for new meningitis B vaccines
June 24, 2015 at 15:24 PM EDT
June 24 (Reuters) - The U.S. Centers for Disease Control and Prevention on Wednesday recommended that decisions to use new meningitis B vaccines from Pfizer and GlaxoSmithKline in people aged 16 to 23 be made on an individual patient basis by physicians, the companies said, potentially paving the way for wider access to the drugs.